Vestal Point Capital, LP Chimerix Inc Transaction History
Vestal Point Capital, LP
- $1.32 Trillion
- Q3 2024
A detailed history of Vestal Point Capital, LP transactions in Chimerix Inc stock. As of the latest transaction made, Vestal Point Capital, LP holds 1,400,000 shares of CMRX stock, worth $4.68 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
1,400,000
Previous 1,400,000
-0.0%
Holding current value
$4.68 Million
Previous $1.23 Billion
6.16%
% of portfolio
0.1%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding CMRX
# of Institutions
70Shares Held
37MCall Options Held
52.7KPut Options Held
130K-
Ra Capital Management, L.P. Boston, MA8.8MShares$29.4 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.33MShares$14.5 Million0.0% of portfolio
-
Monaco Asset Management Sam4.22MShares$14.1 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.4MShares$8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.21MShares$7.37 Million0.03% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $293M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...